Page last updated: 7 August 2017
The PBAC is an independent expert body appointed by the Australian Government. Members include doctors, health professionals, health economists and consumer representatives.
Its primary role is to recommend new medicines for listing on the PBS. No new medicine can be listed unless the committee makes a positive recommendation. The PBAC meets three times a year, usually in March, July and November.
When recommending a medicine for listing, the PBAC takes into account the medical conditions for which the medicine was registered for use in Australia, its clinical effectiveness, safety and cost-effectiveness (‘value for money’) compared with other treatments.
PBAC has two sub-committees to assist with analysis and advice in these areas:
Contact details for the PBAC can be found in PBS Contacts
Agendas, outcomes and public summary documents of PBAC meetings can be found under elements of the listing process
Professor Andrew Wilson is the Chair of the PBAC. He has specialist professional qualifications in clinical medicine and public health medicine and a PhD in epidemiology.
Ms Jo Watson is the Deputy Chair of the PBAC. She is also the Chair of the Health Technology Assessment Consumer Consultative Committee, Deputy Chair of the Consumers Health Forum, and a long standing consumer nominee and advocate.
Dr Peggy Brown is a psychiatrist from Queensland and is a Fellow of the Australian and New Zealand College of Psychiatrists.
Ms Michelle Burke is the industry nominee. She has more than 20 years of experience in the pharmaceutical industry, contributing in areas which include access to medicines and industry development.
Professor Clara Chow is a clinician-scientist (Cardiologist) and Director of the Cardiovascular Division at The George Institute. She also has an established national and international reputation in Cardiovascular Disease prevention research.
Professor Jonathan Craig is a senior staff specialist in paediatric nephrology from the Children’s Hospital at Westmead, NSW. He holds his professorship in Clinical Epidemiology at the School of Public Health, University of Sydney. He is also a current member of Medical Services Advisory Committee (MSAC).
Professor Christopher Etherton-Beer is a clinical academic in Geriatric Medicine at the University of Western Australia and is a Geriatrician/ Clinical Pharmacologist at Royal Perth Hospital. Professor Etherton-Beer has research interests in ageing and aged care, stroke, medical education and pharmaco-geriatrics. He is also Chair of the Drug Utilisation Sub Committee of the PBAC.
Associate Professor Peter Grimison is a medical oncologist at the Chris O’Brien Lifehouse in Sydney, and conducts clinical research at the University of Sydney.
Dr (Peter) Shane Hamblin is the head of unit, Endocrinology and Diabetes for Western Health, Melbourne and is also a consultant endocrinologist at the Alfred Hospital. He also has current university appointments with the University of Melbourne and Monash University.
Ms Bel Harper is the second consumer nominee. She has been heavily involved with consumer representation focusing around people with chronic illnesses.
Professor Catherine Hill is a senior consultant rheumatologist at the Queen Elizabeth and Royal Adelaide Hospitals. She is also a current member of the Drug Utilisation Sub-Committee of the PBAC, with extensive experience in epidemiology.
Professor Phoebe Joy Ho is a Senior Staff Specialist in Haematology, Institute of Haematology, Royal Prince Alfred Hospital and Clinical Professor, Faculty of Medicine, University of Sydney. She is one of the principal investigators of the Myeloma Research Unit at Royal Prince Alfred Hospital.
Professor Kirsten Howard is a Professor of Health Economics at the School of Public Health, University of Sydney. She is also Chair of the Economics Sub-Committee of the PBAC, with extensive experience in the health economics field.
Dr Elizabeth Marles is a former President of the Royal Australian College of General Practitioners. She is a senior staff specialist in general practice and Director of the Hornsby-Brooklyn GP Unit and is a Fellow of the Royal Australian College of General Practitioners (RACGP).
Associate Professor David Newby is a community pharmacist in Newcastle, acting Discipline Lead in Clinical Pharmacology, Joint Medical Program, and the Course coordinator for Epidemiology and pharmacoeconomics, Master of Pharmacy Program in the Faculty of Health at the University of Newcastle.
Dr Meena Okera is a medical oncologist at the Adelaide Cancer Centre. She is also a Fellow of the Royal Australasian College of Physicians with extensive experience and involvement to the development of the Northern Territory Cancer Plan.
Dr Ray Parkin is a consultant physician and cardiologist who has vast experience working in rural and regional areas of NSW.
Professor Andrew Roberts is a practising Clinical Haematologist and medical researcher at the Royal Melbourne Hospital. He holds the Metcalf Chair of Leukaemia Research at the University of Melbourne and is a National Health and Medical Research Council (NHMRC) Practitioner Fellow at The Walter and Eliza Hall Institute of Medical Research.
Dr Rashmi Sharma is a practising general practitioner and Practice Principal of a large multidisciplinary teaching practice in Canberra. She holds an Adjunct Associate Professor title at the ANU Medical School. She is also a medical educator and contributes to a number of Commonwealth and local committees related to health.
Dr Thomas Snelling is an infectious diseases consultant at the Princess Margaret Hospital (Perth). He is also the Scientific Director of the Wesfarmers Centre of Vaccines and Infectious Diseases at the Telethon Kids Institute.
Professor Robyn Ward is the Deputy Vice-Chancellor of University of Queensland, and Director of Cancer Services for Prince of Wales Hospital Sydney. She is a practising medical oncologist and a medical researcher and Chairs the Medical Services Advisory Committee.